{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "We performed a randomized controlled trial using a radiostereometric analysis"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "This parallel-group trial (ClinicalTrials.gov: NCT01966848 ) randomized 50 patients"
      },
      "Participants": {
        "score": 2,
        "evidence": "randomized 50 patients with an intact ACL who were eligible to undergo TKA"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomized 50 patients...to receive either a bicruciate-retaining or cruciate-retaining TKA"
      },
      "Objective": {
        "score": 1,
        "evidence": "We performed a randomized controlled trial using a radiostereometric analysis and asked, at 2 years: (1) Is there a difference in tibial implant migration between the bicruciate-retaining and cruciate-retaining TKA designs?"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the maximum total point motion (MTPM) of the tibial component measured with model-based radiostereometric analysis (RSA) at 2 years postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Patients were blinded to treatment allocation."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Patients were blinded to treatment allocation."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "randomized 50 patients with an intact ACL"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "RSA images were available for 22 patients who underwent bicruciate-retaining and 23 patients who underwent cruciate-retaining TKA, while patient-reported outcome measures were available for 24 patients in each group."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The median (interquartile range [IQR]) MTPM was 0.52 mm (0.35 to 1.02) and 0.42 mm (0.34 to 0.70) in the bicruciate-retaining and cruciate-retaining groups, respectively (p = 0.63)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Three patients in the bicruciate-retaining group underwent arthroscopically assisted manipulation at 3 to 4 months postoperatively, and one patient in the bicruciate-retaining group sustained a tibial island fracture during primary surgery and underwent a revision procedure after 6 months."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "ClinicalTrials.gov: NCT01966848"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 21,
    "max_score": 25
  },
  "model": "gpt-4o"
}